Indaptus TherapeuticsINDP
13F holders, Q2 2025 (June 30)5holders
$10.53avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Indaptus Therapeutics Inc. (INDP) in their 13F filings. The largest holders were SBI Securities Co., Ltd. ($2K), Tower Research Capital LLC (TRC) ($1K) and Bank of America Corp. ($327).
- Company
- Indaptus Therapeutics Inc.
- CUSIP
- 45339J204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $3K |
| Exits | 0 | $0 |
Ownership 5 holders
| SBI Securities Co., Ltd. | 0.00% | New | 156 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 108 | $1K |
| Bank of America Corp. | 0.00% | New | 31 | $327 |
| FMR LLC | 0.00% | New | 10 | $105 |
| Wells Fargo & Company | 0.00% | New | 2 | $21 |
"% of holder's portfolio" is INDP's weight in each manager's 13F, not the share of Indaptus Therapeutics Inc. the manager owns.